Table 5.
Proportion of colonoscopies performed beyond 7 mo and proportion of serious adverse events, according to the characteristics of the cohort of gastroenterologists who performed at least one colonoscopy in each of the three periods (guaiac fecal occult blood test, fecal immunochemical test, STOP-fecal immunochemical test, and COVID)
|
Characteristics of the cohort of gastroenterologists
|
Proportion of colonoscopies performed beyond 7 mo by period
|
Proportion of serious adverse events by period
|
||||||||
|
gFOBT
|
FIT
|
STOP-FIT
|
COVID
|
P
1
|
gFOBT
|
FIT
|
STOP-FIT
|
COVID
|
P
1
|
|
|
Nb of Colo (% > 7 mo)
|
Nb of Colo (% > 7 mo)
|
Nb of Colo (% > 7mo)
|
Nb of Colo (% > 7 mo)
|
%EI
|
%EI
|
|
%EI
|
|||
| Overall | 21509 (5.3) | 38352 (6.2) | 7342 (11.3) | 7995 (9.2) | < 10-3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.10 |
| Annual Nb of Colo | ||||||||||
| 1 | 304 (10.1) | 150 (11.8) | 38 (18.4) | 51 (12.0) | < 10-3 | 0.3 | 0 | 0 | 0 | 0.67 |
| 2-30 | 16819 (5.5) | 15970 (6.9) | 4887 (11.8) | 4211 (9.4) | < 10-3 | 0.3 | 0.4 | 0.3 | 0.1 | 0.09 |
| 31-100 | 4386 (4.1) | 21137 (5.7) | 2817 (10.6) | 3733 (9.0) | < 10-3 | 0.4 | 0.2 | 0.3 | 0.2 | 0.25 |
| > 100 | 1095 (3.7) | 0.2 | ||||||||
| Place of Colo performance | ||||||||||
| Clinic | 15745 (4.8) | 27003 (5.4) | 5039 (10.4) | 5560 (8.3) | < 10-3 | 0.3 | 0.3 | 0.3 | 0.1 | 0.16 |
| Private hospital | 3041 (5.1) | 6500 (5.9) | 1359 (9.6) | 1621 (9.5) | < 10-3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.71 |
| Public hospital | 2723 (8.5) | 4849 (10.6) | 940 (18.8) | 795 (15.1) | < 10-3 | 0.6 | 0.6 | 0.2 | 0.4 | 0.48 |
| Average density of GE (GE/100000 iHbts) | ||||||||||
| Low | 4643 (5.1) | 8419 (5.8) | 1519 (11.5) | 1800 (9.1) | < 10-3 | 0.3 | 0.2 | 0.3 | 0.1 | 0.59 |
| Average | 3245 (4.9) | 4314 (6.5) | 810 (11.0) | 781 (9.9) | < 10-3 | 0.2 | 0.3 | 0.1 | 0.5 | 0.48 |
| High | 13621 (5.5) | 25619 (6.2) | 5009 (11.3) | 5395 (9.2) | < 10-3 | 0.4 | 0.3 | 0.3 | 0.1 | 0.04 |
| Annual Nb of Colo locations | ||||||||||
| 1 location | 14437 (5.6) | 24851 (6.3) | 4763 (10.6) | 5160 (9.5) | < 10-3 | 0.4 | 0.3 | 0.3 | 0.2 | 0.17 |
| ≥ 2 location | 7072 (4.8) | 13501 (6.0) | 2575 (12.7) | 2816 (8.7) | < 10-3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.80 |
| Residence of the patient | ||||||||||
| Colonoscopy’s supply municipality | 4947 (4.9) | 7775 (5.9) | 1502 (11.6) | 1530 (8.0) | < 10-3 | 0.2 | 0.3 | 0.3 | 0.0 | 0.18 |
| Other municipality in Colonoscopy’s supply department | 13259 (5.1) | 23754 (6.0) | 4401 (11.0) | 4982 (9.6) | < 10-3 | 0.4 | 0.3 | 0.2 | 0.2 | 0.02 |
| Other departments in IDF | 3303 (6.6) | 6823 (6.9) | 1435 (12.1) | 1464 (9.2) | < 10-3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.80 |
| Age (in yr) of the patients | ||||||||||
| 50-54 | 4995 (6.7) | 8018 (7.0) | 1695 (12.2) | 1616 (11.0) | < 10-3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.43 |
| 55-59 | 4669 (5.7) | 7355 (6.6) | 1446 (11.8) | 1560 (9.9) | < 10-3 | 0.3 | 0.3 | 0.4 | 0.2 | 0.79 |
| 60-64 | 4889 (4.7) | 7851 (5.9) | 1478 (10.3) | 1531 (8.9) | < 10-3 | 0.4 | 0.3 | 0.5 | 0.3 | 0.76 |
| 65-69 | 3766 (4.4) | 8511 (5.5) | 1403 (11.7) | 1590 (8.2) | < 10-3 | 0.4 | 0.3 | 0.3 | 0.1 | 0.20 |
| ≥ 70 | 3190 (4.6) | 6617 (5.7) | 1316 (10.6) | 1679 (8.2) | < 10-3 | 0.5 | 0.4 | 0.2 | 0.2 | 0.49 |
1
Cochran Q test.
Colo: Screening colonoscopy; Colo+: Positive screening colonoscopy; FIT: Fecal immunochemical test; GE: Gastroenterologist; gFOBT: Guaiac fecal occult blood test; iHbts: Inhabitants; IDF: Ile-De-France; Nb: Number.